Stock Events

Stock Events

Arbutus Biopharma (0SGC.LSE) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.12

-0.11

-0.1

-0.09

Details

Expected EPS

-0.094

Actual EPS

-0.1

Surprise EPS

-0.01

Surprise Percent

+6.38%

Description

Arbutus Biopharma (0SGC.LSE) has reported earnings of -0.1 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.